Abstracts tagged "ustekinumab and infliximab"

Abstract Number: 1543 • 2019 ACR/ARP Annual Meeting
Long-Term Effectiveness and Safety of Infliximab, Golimumab and Ustekinumab in Psoriatic Arthritis Patients from a Prospective Observational Registry
Proton Rahman ¹, Regan Arendse ², Isabelle Fortin ³, Andrew Chow ⁴, Majed Khraishi ⁵, Suneil Kapur ⁶, Michel Zummer ⁷, Raheem Kherani ⁸, Jonathan Chan ⁹, Emmanouil Rampakakis ¹⁰, Meagan Rachich ¹¹, Odalis Asin-Milan ¹¹, Allen Lehman ¹¹ and Francois Nantel¹¹, ¹Memorial University, Newfoundland, NL, Canada, ²University of Saskatchewan, Saskatoon, SK, Canada, ³Centre de Rhumatologie de l'Est du Quebec, Rimouski, QC, Canada, ⁴Credit Valley Rheumatology, Mississauga, ON, Canada, ⁵Nexus Clinical Research, Memorial University of Newfoundland, St. Johns, NL, Canada, ⁶University of Ottawa, Ottawa, ON, Canada, ⁷Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ⁸University of British Columbia, Richmond, BC, Canada, ⁹Artus Health Clinic, Vancouver, BC, Canada, ¹⁰JSS Medical Research, Montreal, Canada, ¹¹Janssen Inc., Toronto, ON, Canada
Background/Purpose: Long-term registries are essential to evaluate new therapies in a patient population that differs from clinical trials and usually varies over time. The purpose of…